Search
Dr David Woolf

Dr David Woolf

Clinical oncology 06101982

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Offers

  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

Dr David Woolf is a Consultant Clinical Oncologist at The Christie NHS Foundation Trust. He plans and delivers cutting edge radiotherapy to patients with Breast and Lung Cancer as well as those who have cancers that have spread to other parts of the body (Oligometastasis).

Dr Woolf has extensive experience in the use of Stereotactic Ablative Radiotherapy (SABR/SBRT) and is the lead at the Christie for this technique. With training in the USA, he is accredited in the use of proton beam radiotherapy and also delivers radiotherapy on the MR Linac.

In addition, Dr Woolf treats patients with drug therapies including chemotherapy, endocrine therapy and other targeted drug therapy (such as immunotherapy).

This combination of expertise allows Dr Woolf to work alongside experts from the wider multidisciplinary team including leading surgeons, physicians and radiologists to produce a comprehensive treatment plan for patients.

Patient feedback is that they appreciate Dr Woolf’s personable, honest and prompt approach to their care.

Dr Woolf undertook his Clinical Oncology training in London at the University College Hospital, The Royal Free Hospital and St Bartholomew’s Hospital. In addition, he has a Master’s Degree in Oncology from the Institute of Cancer Research and obtained a Doctorate of Medicine after research at Mount Vernon Cancer Centre.

Dr Woolf is involved in and leads international research including the award of a prestigious multi-million pound National Institute for Heath and Care Research (NIHR) grant to study lung radiotherapy and leading global research collaborations. He has authored over 40 research publications and over 70 national and international presentations. He is also involved in the professional training of Clinical Oncologists nationally through the Royal College of Radiologists.

Most of his spare time is taken up with his young family but outside of this he enjoys exercising regularly and reads widely.

Areas of interest

Lung cancer; Breast cancer; Radiotherapy; SABR ( Stereotactic Ablative Body Radiotherapy); SBRT; Systemic therapy; chemotherapy; targeted therapies; hormone therapy / endocrine therapy; Immunotherapies; Proton Beam Therapy; MR Linac

Medical secretaries

My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    The Christie Clinic (5-50)

  • A1080

    Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)

    The Christie Clinic (5-50)

  • X6772

    Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)

    The Christie Clinic (5-50)

  • X6950

    Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (1-5)

    The Christie Clinic (1-5)

  • A1070

    Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)

    The Christie Clinic (1-5)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)

    The Christie Clinic (1-5)

  • Show All (8 )...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.